Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,073.80
-24.20 (-2.20%)
Last updated: Mar 9, 2026, 9:51 AM IST
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 11.08 billion as of March 6, 2026. Its market cap has decreased by -37.41% in one year.
Market Cap
11.08B
Enterprise Value
11.32B
Revenue
3.85B
Ranking
n/a
PE Ratio
27.77
Stock Price
1,073.80
Market Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 11.08B, an increase of 1,110.05%. That is a compound annual growth rate of 34.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.08B | -29.12% |
| Dec 31, 2025 | 15.64B | -19.04% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 40.23B |
| Innova Captab | 38.91B |
| RPG Life Sciences | 30.97B |
| Orchid Pharma | 25.79B |
| Solara Active Pharma Sciences | 22.11B |
| Indoco Remedies | 18.31B |
| Windlas Biotech | 15.58B |
| Ind-Swift Laboratories | 11.87B |